Abstract: A waste disposal system for receiving pharmaceutical waste material including at least one of a solid phase pharmaceutical waste material and a liquid phase pharmaceutical waste material is provided. The waste receiver includes a receiver body defining an opening. The waster receiver further includes an inner surface defining a container volume in fluid communication with the opening, and an outer surface opposite the inner surface. The outer surface defines a lock passageway separate from the opening. The system further includes a bracket adapted to be secured to a fixed surface and a locking assembly coupled to the bracket and adapted to releasably secure the waste receiver to the fixed surface. The locking assembly includes a lock housing sized to be removably positioned at least partially within the lock passageway.

Abstract: A waste receiver for receiving pharmaceutical waste material and adapted to be releasably secured to a fixed surface is disclosed. The waste receiver comprises a receiver body with a fluid absorber and a chemical composition disposed within the receiver body. The receiver body defines an opening for receiving the pharmaceutical waste material and comprises an inner surface defining a container volume in fluid communication with the opening, and an outer surface opposite the inner surface with the outer surface defining a lock passageway through the receiver body and a keyway comprising a portion of the lock passageway. The lock passageway is adapted to receive a locking assembly and the keyway is adapted to receive an engagement feature of the locking assembly to releasably secure the waste receiver to the locking assembly in a single orientation. The waste receiver also comprises a cover adapted to be coupled with the receiver body.

Abstract: An assembly for receiving fluid pharmaceutical waste into a fluid waste receiver includes a fluid receiver body coupled to a fluid receiver cap, and receiving solid pharmaceutical waste into a solid waste receiver includes a solid receiver body coupled to a solid receiver cap. The assembly comprises a receiver housing and a receiver lid coupled to the receiver housing. The receiver housing comprises a retainer base, sidewalls extending from the retainer base, and dividers extending from the sidewalls to divide an interior of the receiver housing into a receiver compartment configured to receive the fluid receiver body and the solid receiver body, and a cap compartment. A first of the dividers divides the receiver compartment from a first of the cap compartments configured to receive the fluid receiver cap, and a second one of the dividers divides the receiver compartment from a second of the cap compartments configured to receive the solid receiver cap.

Abstract: A waste receiver for receiving pharmaceutical waste material and adapted to be releasably secured to a fixed surface is disclosed. The waste receiver comprises a receiver body with a fluid absorber and a chemical composition disposed within the receiver body. The receiver body defines an opening for receiving the pharmaceutical waste material and comprises an inner surface defining a container volume in fluid communication with the opening, and an outer surface opposite the inner surface with the outer surface defining a lock passageway through the receiver body and a keyway comprising a portion of the lock passageway. The lock passageway is adapted to receive a locking assembly and the keyway is adapted to receive an engagement feature of the locking assembly to releasably secure the waste receiver to the locking assembly in a single orientation. The waste receiver also comprises a cover adapted to be coupled with the receiver body.

Abstract: A waste disposal system with a waste receiver for receiving pharmaceutical waste material. A locking assembly is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall of a receiver body of the waste receiver to engage a locking feature of the cover in the locked configuration. A cover retention feature may prevent axial decoupling of the cover from the receiver body. An engagement feature is moved to be disengaged from the receiver body, and the receiver body is moved away from the fixed surface to disengage the locking assembly from the cover. The cover is decoupled from the cover retention feature, and coupled with the receiver body to seal the pharmaceutical waste material. The locking assembly may be removed from a lock passageway for disposal of the waste receiver.

Abstract: A pharmaceutical waste disposal assembly includes a fluid receiver body for receiving fluid pharmaceutical waste, said fluid receiver body may comprise a material that is clear, opaque, or otherwise see-through and having a capacity. The assembly also includes a first reaction agent positioned within the fluid receiver body, the fluid pharmaceutical waste contacting the first reaction agent to change the fluid pharmaceutical waste in one of a chemical and physical manner so that the fluid pharmaceutical waste is rendered unrecoverable. The assembly also includes a fluid absorber positioned within said fluid receiver body, said fluid absorber configured to absorb and retain fluid pharmaceutical waste deposited in said fluid receiver body. The assembly also includes a moisture-sensitive visual indicator that changes color when fluid pharmaceutical waste deposited in said fluid receiver body has reached a predetermined percentage of said capacity of said fluid receiver body.

Abstract: The present disclosure provides a method of disposing of a residual pharmaceutical composition from an IV bag. The method of disposing also includes coupling the IV bag to a pharmaceutical dispenser coupler. The disposing also includes extracting at least a portion of the residual pharmaceutical composition from the IV bag through the pharmaceutical dispenser coupler. The disposing also includes treating at least a portion of the extracted pharmaceutical composition in one of a chemical and physical manner.

Abstract: A waste disposal system (30) with a waste receiver (32) for receiving pharmaceutical waste material. A locking assembly (34) is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall (44) of a receiver body (36) of the waste receiver to engage a locking feature of a cover (82) in the locked configuration. A cover retention feature (124) may prevent axial decoupling of the cover from the receiver body. The receiver body may be formed from two shells (62,64). A reaction agent (150) is positioned within the container volume and spaced apart from a bottom wall of the receiver body. The reaction agent may be positioned within the container volume between the lock passageway (94) and/or a solid receiver volume, and opposing sidewalls of the receiver body. A support may maintain the position of the reaction agent within the container volume.

Abstract: A pharmaceutical waste system for treating a residual pharmaceutical composition disposed in a pharmaceutical dispenser includes an extraction stage, a pharmaceutical dispenser coupler, and a pharmaceutical waste treatment stage. The extraction stage is in fluid communication with the pharmaceutical dispenser and is configured to extract at least a portion of the residual pharmaceutical composition from the pharmaceutical dispenser. The pharmaceutical dispenser coupler is configured to couple the pharmaceutical dispenser to the extraction stage. The pharmaceutical waste treatment stage is in fluid communication with the extraction stage and is configured to change the residual pharmaceutical waste composition extracted from the pharmaceutical dispenser in one of a chemical and physical manner. The present disclosure also provides a method of disposing of a residual pharmaceutical composition from a pharmaceutical dispenser.

Abstract: A waste disposal system with a waste receiver for receiving pharmaceutical waste material. A locking assembly is secured to a fixed surface and actuated from a locked configuration to an unlocked configuration. A lock cylinder of the locking assembly may extend forward of a front wall of a receiver body of the waste receiver to engage a locking feature of the cover in the locked configuration. A cover retention feature may prevent axial decoupling of the cover from the receiver body. An engagement feature is moved to be disengaged from the receiver body, and the receiver body is moved away from the fixed surface to disengage the locking assembly from the cover. The cover is decoupled from the cover retention feature, and coupled with the receiver body to seal the pharmaceutical waste material. The locking assembly may be removed from a lock passageway for disposal of the waste receiver.

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste comprises a first receiver body (19) and a first reaction agent (287). The first receiver body (19) receives the pharmaceutical waste. The first receiver body (19) includes a receiver bottom (283). The first reaction agent (287) is positioned within the first receiver body (19) and spaced apart from the receiver bottom (283). The pharmaceutical waste reacts with the first reaction agent (287) to change the pharmaceutical waste in one of a chemical and physical manner so that the pharmaceutical waste is unrecoverable. The first receiver body (19) can receive fluid pharmaceutical waste and/or solid pharmaceutical waste. The first reaction agent (287) may include one or more of a denaturant, an emetic and a bittering agent. For example, the first reaction agent (287) may include one or more of quinine, ipecac and denatonium benzoate.

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste includes a first receiver body and a second receiver body. The assembly further includes a first reaction agent and a second reaction agent. The first reaction agent and the second reaction agent renders the pharmaceutical waste unrecoverable. The first reaction agent can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent can include activated charcoal.

Abstract: The present disclosure provides a pharmaceutical waste system for treating a residual pharmaceutical composition disposed in a pharmaceutical dispenser. The pharmaceutical waste system includes an extraction stage, a pharmaceutical dispenser coupler, and a pharmaceutical waste treatment stage. The extraction stage is in fluid communication with the pharmaceutical dispenser and is configured to extract at least a portion of the residual pharmaceutical composition from the pharmaceutical dispenser. The pharmaceutical dispenser coupler is configured to couple the pharmaceutical dispenser to the extraction stage. The pharmaceutical waste treatment stage is in fluid communication with the extraction stage and is configured to change the residual pharmaceutical waste composition extracted from the pharmaceutical dispenser in one of a chemical and physical manner. The present disclosure also provides a method of disposing of a residual pharmaceutical composition from a pharmaceutical dispenser.

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste includes a first receiver body and a second receiver body. The assembly further includes a first reaction agent and a second reaction agent. The first reaction agent and the second reaction agent renders the pharmaceutical waste unrecoverable. The first reaction agent can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent can include activated charcoal.

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste includes a receiver body (19) and a first reaction agent (287). The receiver body (19) is configured to receive the pharmaceutical waste. The receiver body (19) includes a body interior wall (921A) that defines a body interior (921B). The first reaction agent (287) is positioned within the body interior (921B) so that the first reaction agent (287) contacts the body interior wall (921A) prior to receiving the pharmaceutical waste. The first reaction agent (287) chemically reacts with the pharmaceutical waste so that the pharmaceutical waste is rendered unrecoverable. The first reaction agent (287) can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent (287) can include activated charcoal.

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste includes a receiver body (19) and a first reaction agent (287). The receiver body (19) is configured to receive the pharmaceutical waste. The receiver body (19) includes a body interior wall (921A) that defines a body interior (921B). The first reaction agent (287) is positioned within the body interior (921B) so that the first reaction agent (287) contacts the body interior wall (921A) prior to receiving the pharmaceutical waste. The first reaction agent (287) chemically reacts with the pharmaceutical waste so that the pharmaceutical waste is rendered unrecoverable. The first reaction agent (287) can include at least one of a denaturant and a deterrent. Additionally, the first reaction agent (287) can include activated charcoal.

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of fluid pharmaceutical waste comprises a fluid receiver body (219) and a fluid absorber (270A). The fluid receiver body (219) receives the fluid pharmaceutical waste. The fluid absorber (270A) is positioned within the fluid receiver body (219). The fluid absorber (270A) absorbs and retains the fluid pharmaceutical waste. The fluid absorber (270A) includes a plurality of levels (270L, 270M, 270U) that are spaced apart from one another. The plurality of levels (270L, 270M, 270U) can be oriented substantially vertically relative to one another so that the fluid pharmaceutical waste is distributed to each of the plurality of levels (270L, 270M, 270U) of the fluid absorber (270A).

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of raw pharmaceutical waste comprises a first receiver body (19) and a first reaction agent (287). The first receiver body (19) receives the pharmaceutical waste. The first receiver body (19) includes a receiver bottom (283). The first reaction agent (287) is positioned within the first receiver body (19) and spaced apart from the receiver bottom (283). The pharmaceutical waste reacts with the first reaction agent (287) to change the pharmaceutical waste in one of a chemical and physical manner so that the pharmaceutical waste is unrecoverable. The first receiver body (19) can receive fluid pharmaceutical waste and/or solid pharmaceutical waste. The first reaction agent (287) may include one or more of a denaturant, an emetic and a tittering agent. For example, the first reaction agent (287) may include one or more of quinine, ipecac and denatonium benzoate.

Abstract: A pharmaceutical waste disposal assembly (10) for disposing of fluid pharmaceutical waste comprises a fluid receiver body (219) and a fluid absorber (270A). The fluid receiver body (219) receives the fluid pharmaceutical waste. The fluid absorber (270A) is positioned within the fluid receiver body (219). The fluid absorber (270A) absorbs and retains the fluid pharmaceutical waste. The fluid absorber (270A) includes a plurality of levels (270L, 270M, 270U) that are spaced apart from one another. The plurality of levels (270L, 270M, 270U) can be oriented substantially vertically relative to one another so that the fluid pharmaceutical waste is distributed to each of the plurality of levels (270L, 270M, 270U) of the fluid absorber (270A).

Abstract: A pharmaceutical waste disposal assembly (10) comprises a waste receiver (212) that receives pharmaceutical waste, the waste receiver (212) including a radio frequency identification tag (200) that is configured to transmit a radio frequency signal that identifies the waste receiver (212). The pharmaceutical waste disposal assembly (10) can further comprise a receiver retainer (1516) that selectively receives the waste receiver (212). The radio frequency identification tag (200) is configured to transmit the radio frequency signal that is usable to track a location of the waste receiver (212) regardless of whether or not the waste receiver (212) is positioned within the receiver retainer (1516). The receiver retainer (1516) can include an identification reader (1500) that reads the radio frequency signal and is configured to store information from the radio frequency signal that inhibits use of the waste receiver (212) following removal from and repositioning into the receiver retainer (1516).